Come atteso, diete ad elevato tenore lipidico, ed in particolare arricchite di colesterolo esogeno, hanno determinato un importante impatto non solo sui parametri biochimici lipidemici e glicemici, ma anche impatti evidenti sulla morfologia epatica e naturalmente un significativo accumulo di adiposità addominale. Lo studio condotto su un estratto di
Eruca sativa L. ha consentito di evidenziare che tale estratto, presumibilmente in
funzione di un apporto di metaboliti secondari, se da un lato non sembra aver portato ad effetti significativi sul metabolismo del colesterolo nel suo complesso, dall’altro sembra aver esercitato effetti significativi sul metabolismo dei trigliceridi e forse anche su quello del glucosio; effetti che si sono tradotti in un significativo contenimento dell’accrescimento ponderale e della adiposità viscerale associata ad una dieta ad elevato tenore lipidico. Tale risultato sperimentale, che suggerisce un’originale e interessante applicazione di estratti ricchi in glucosinolati di piante Brassicaceae.
77
BIBLIOGRAFIA
Abdull Razis AF, Bagatta M, De Nicola GR, Iori R, Ioannides C. Intact glucosinolates
modulate hepatic cytochrome P450 and phase II conjugation activities and may contribute directly to the chemopreventive activity of cruciferous vegetables. Toxicology,
2010; 277: 74-85.
Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derré A, Villéger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet, 2003; 34:154–156.
Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol lowering agents: a
meta-analysis of randomized controlled trials. Food Nutr Res, 2008; 52.
Adachi T, Cohen RA. Decreased aortic glutathione levels may contribute to impaired
nitric oxide-induced relaxation in hypercholesterolaemia. Br J Pharmacol, 2000;
129:1014–20 31.
Affuso F, Ruvolo A, Micillo F, Saccà L, Fazio S. Effects of a nutraceutical combination
(berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis, 2010;
20:656-661.
Aiso I, Inoue H, Seiyama Y, Kuwano T. Compared with the intake of commercial vegetable
juice, the intake of fresh fruit and komatsuna (Brassica rapa L. var. perviridis) juice mixture reduces serum cholesterol in middle-aged men: a randomized controlled pilot study. Lipids Health Dis, 2014; 13, 102.
Alevizos A, Mihas C, Mariolis A. Advertising campaigns of sterol-enriched food. An often
neglected cause of reduced compliance to lipid lowering drug therapy. Cardiovasc Drugs
Ther, 2007; 21:133-134.
Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy-
78
Andersson SW, Skinner J, Ellegård L, Welch AA, Bingham S, Mulligan A, Andersson H, Khaw KT. Intake of dietary plant sterols is inversely related to serum cholesterol
concentration in men and women in the EPIC Norfolk population: a cross-sectional study.
Eur J Clin Nutr, 2004; 58:1378-1385
Armah CN, Derdemezis C, Traka MH, Dainty JR, Doleman JF, Saha S, Leung W, Potter JF, Lovegrove JA, Mithen RF. Diet rich in high glucoraphanin broccoli reduces plasma LDL
cholesterol: Evidence from randomised controlled trials. Mol Nutr Food Res, 2015;
May;59(5):918-26.
Asdaq SM, Inamdar MN. Potential of Crocus sativus (saffron) and its constituent, crocin,
as hypolipidemic and antioxidant in rats. Appl Biochem Biotechnol, 2010; 162: 358-372.
Assmann G, Buono P, Daniele A, Della Valle E, Farinaro E, Ferns G, Krogh V, Kromhout D, Masana L, Merino J, Misciagna G, Panico S, Riccardi G, Rivellese AA, Rozza F, Salvatore F, Salvatore V, Stranges S, Trevisan M, Trimarco B, Vetrani C. Functional foods and
cardiometabolic diseases* International Task Force for Prevention of Cardiometabolic Diseases. Nutr Metab Cardiovasc Dis, 2014; 24:1272-1300.
Bahadoran Z, Mirmiran P, Azizi F. Potential efficacy of broccoli sprouts as a unique
supplement for management of type 2 diabetes and its complications. J Med Food, 2013;
16, 375–382.
Baker WL, Baker EL, Coleman CI. The effect of plant sterols or stanols on lipid parameters
in patients with type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract, 2009; 84:e33-
e37.
Bazzano LA, Thompson AM, Tees MT, Nguyen CH, Winham DM. Non-soy legume
consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials.
Nutr Metab Cardiovasc Dis, 2011; 21:94-103.
Becker DJ, French B, Morris PB, Silvent E, Gordon RY. Phytosterols, red yeast rice, and
lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial. Am Heart J, 2013; 166:187-196.
Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for
dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med, 2009;
79
Benkhedda K, Boudrault C, Sinclair SE, Marles RJ, Xiao CW, Underhill L. Health Canada's
proposal to accept a health claim about soy products and cholesterol lowering. Int Food
Risk Anal J, 2014; 4:1–12.
Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of
policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA, 2006; 295:2262–9.
Björkman M, Klingen I, Birch AN, Bones AM, Bruce TJ, Johansen TJ, Meadow R, Mølmann J, Seljåsen R, Smart LE, Stewart D. Phytochemicals of Brassicaceae in plant protection
and human health--influences of climate, environment and agronomic practice.
Phytochemistry, 2011; 72, 538-556.
Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. Niacin in patients with low HDL cholesterol levels
receiving intensive statin therapy. N Engl J Med, 2011; 365:2255–2267.
Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters DD, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM Jr, Ridker PM, Grundy SM, Kastelein JJ.
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta- analysis of statin trials. J Am Coll Cardiol, 2014; 64:485–494.
Bonaccio M, Bonanni AE, Di Castelnuovo A, De Lucia F, Donati MB, de Gaetano G, Iacoviello L, Moli-sani Project Investigators. Low income is associated with poor
adherence to a Mediterranean diet and a higher prevalence of obesity: cross-sectional results from the Moli-sani study. BMJ Open, 2012; 2(6).
Bones AM, Rossiter JT. The enzymic and chemically induced decomposition of
glucosinolates. Phytochemistry, 2006; 67: 1053-67.
Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber:
a meta-analysis. Am J Clin Nutr, 1999; 69:30-42
Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, Issandou M. Inhibition
of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res, 2006; 47:1281-2188.
80
Burke FM. Red yeast rice for the treatment of dyslipidemia. Curr Atheroscler Rep, 2015 Apr; 17:495.
Cameron J, Ranheim T, Kulseth MA, Leren TP, Berge KE. Berberine decrease PCSK9
expression in HepG2 cells. Atherosclerosis, 2008; 201:266–273.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM. Ezetimibe added
to statin therapy after acute coronary syndromes. N Engl J Med, 2015; 372:2387–2397.
Castellanos-Jankiewicz A, Del Bosque-Plata L, Tejero ME. Combined effect of plant
sterols and dietary fiber for the treatment of hypercholesterolemia. Plant Foods Hum
Nutr, 2014; 69:93-100.
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL. 2016 ESC/EAS Guidelines
for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).
Atherosclerosis, 2016; 253:281-344.
Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis, 2011;
217:3-46.
Chapman K. Can people make healthy changes to their diet and maintain them in the
long term? A review of the evidence. Appetite, 2010; 54:433-441.
Chasman DI, Giulianini F, MacFadyen J, Barratt BJ, Nyberg F, Ridker PM. Genetic
81
Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Circ Cardiovasc Genet, 2012; 5:257–264.
Chen JT1, Wesley R, Shamburek RD, Pucino F, Csako G. Meta-analysis of natural
therapies for hyperlipidemia: plant sterols and stanols versus policosanol.
Pharmacotherapy 2005; 25:171-83.
Chen XL, Dodd G, Kunsch C. Sulforaphane inhibits TNF-alpha-induced activation of p38
MAP kinase and VCAM-1 and MCP-1 expression inendothelial cells. Inflamm Res, 2009;
58:513–2128.
Chen ZY, Ma KY, Liang Y, Peng C, Zuo Y. Role and classification of cholesterol-lowering
functional foods. Journal of Functional Foods, 2011; 3:61-69.
Choi KM, Lee YS, Kim W, Kim,SJ, et al. Sulforaphane attenuates obesitybyi nhibiting
adipogenesis and activating the AMPK pathway in obese mice. J. Nutr. Biochem, 2014;
25, 201–207.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more
intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials. Lancet, 2010; 376: 1670–1681.
Chutkan R, Fahey G, Wright WL, McRorie J. Viscous versus nonviscous soluble fiber
supplements: mechanisms and evidence for fiber-specific health benefits. J Am Acad
Nurse Pract, 201; 24:476-487.
Cicero AF, Rovati LC, Setnikar I. Eulipidemic effects of berberine administered alone or in
combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. Arzneimittelforschung, 2007; 57:26-30.
Clifton PM, Noakes M, Sullivan D, Erichsen N, Ross D, Annison G, Fassoulakis A, Cehun M, Nestel P. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt,
bread and cereal. Eur J Clin Nutr, 2004; 58:503-509.
Cobiac LJ, Magnus A, Lim S, Barendregt JJ, Carter R, Vos T. Which interventions offer best
value for money in primary prevention of cardiovascular disease?. PLoS One, 2012;
82
Collins M, Mason H, O'Flaherty M, Guzman-Castillo M, Critchley J, Capewell S. An
economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study. Value Health, 2014; 17:517–524.
Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Cascio V, Sawamura T. Oxidized low density lipoprotein (ox-LDL)
binding to ox-LDL receptor- 1 in endothelial cells induces the activation of NF-kappaB through anincreased production of intracellular reactive oxygen species. J Biol Chem,
2000; 275:1263–83.
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk
of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003; 24:987–
1003.
Conzatti A, Fróes FC, Schweigert Perry ID, Souza CG. Clinical and molecular evidence of
the consumption of broccoli, glucoraphanin and sulforaphane in humans. Nutr Hosp,
2014; 31(2):559-69
Cust AE, Skilton MR, van Bakel MM, Halkjaer J, Olsen A, Agnoli C et al. Total dietary
carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr, 2009; 63:S37-S60.
Cust AE, Skilton MR, van Bakel MM, Halkjaer J, Olsen A, Agnoli C. Total dietary
carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr, 2009; 63:S37-S60.
Dahl WJ, Stewart ML. Position of the Academy of Nutrition and Dietetics: Health
Implications of Dietary Fiber. J Acad Nutr Diet, 2015; 115:1861-1870.
De Natale C, Annuzzi G, Bozzetto L, Mazzarella R, Costabile G, Ciano O, Riccardi G, Rivellese AA. Effects of a plant-based high-carbohydrate/high-fiber diet versus high-
monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care, 2009; 32:2168-2173.
83
Del Boccio G, Lapenna D, Porreca E, Pennelli A, Savini F, Feliciani P, Ricci G, Cuccurullo F.
Aortic antioxidant defence mechanisms: timerelated changes in cholesterol-fed rabbits.
Atherosclerosis, 1990; 81:127–35.
Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA. Continuous dose-response relationship of the LDL-cholesterol-lowering
effect of phytosterol intake. J Nutr, 2009; 139:271-284.
Demonty I, Ras RT, van der Knaap HC, Meijer L, Zock PL, Geleijnse JM, Trautwein EA. The
effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations: a pooled analysis of 12 randomised controlled trials. Eur J Nutr, 2013;
52:153-160.
Descovich GC, Ceredi C, Gaddi A, Benassi MS, Mannino G, Colombo L, Cattin L, Fontana G, Senin U, Mannarino E, Caruzzo C, Bertelli E, Fragiacomo C, Noseda G, Sirtori M, Sirtori CR. Multicentre study of soybean protein diet for outpatient hypercholesterolaemic
patients. Lancet, 1980; 2:709–712.
Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a
systemic review and meta-analysis. Evid Based Complement Alternat Med, 2012;
2012:591654.
Dong H, Zhao Y, Zhao L, Lu F. The effects of berberine on blood lipids: a systemic review
and meta-analysis of randomized controlled trials. Planta Med, 2013; 79:437-446.
Dulin MF, Hatcher LF, Sasser HC, Barringer TA. Policosanol is ineffective in the treatment
of hypercholesterolemia: a randomized controlled trial. Am J Clin Nutr, 2006; 84:1543-8.
European Food Safety Authority. A report from the data collection and exposure unit in
response to a request from the European Commission. EFSA J, 2008; 133:1-21.
European Food Safety Authority. Scientific Opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal, 2012; 10(2):2555.
84
Eussen SR, de Jong N, Rompelberg CJ, Garssen J, Verschuren WM, Klungel OH. Effects of
the use of phytosterol/-stanol-enriched margarines on adherence to statin therapy.
Pharmacoepidemiol Drug Saf, 2010; 19:1225-1232.
Ezzati M, Lopez AD, Rodgers A, Murray CJL. Comparative quantification of health risks:
global and regional burden of disease attributable to selected major risk factors. Geneva:
World Health Organization, 2004.
Fahey JW, Talalay P. Antioxidant functions of sulforaphane: a potent inducer of Phase II
detoxication enzymes. Food Chem Toxicol, 1999; 37:973–9.
Fimognari C, Turrini E, Ferruzzi L, Lenzi M, Hrelia P. Natural isothiocyanates: genotoxic
potential versus chemoprevention. Mutat Res, 2012; 750: 107-31.
Gerards MC, Terlou RJ, Yu H, Koks CH, Gerdes VE. Traditional Chinese lipid-lowering
agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis. Atherosclerosis, 2015; 240:415-423.
Giacco R, Costabile G, Della Pepa G, Anniballi G, Griffo E, Mangione A, Cipriano P, Viscovo D, Clemente G, Landberg R, Pacini G, Rivellese AA, Riccardi G. A whole-grain cereal-based
diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome. Nutr Metab Cardiovasc Dis, 2014; 24:837-844.
Ginsberg NH. The ever-expanding role of degradation in the regulation of apolipoprotein
B metabolism. J Lipid Res, 2009; 50:162-166.
Goldman L, Shafer A. Goldman's Cecil Medicine. 24ª ed, Philadelphia, Elsevier, 2012; cap.70
González-Castejón M, Rodriguez-Casado A. Dietary phytochemicals and their potential
effects on obesity: a review. Pharmacol Res, 2011; 64: 438-55.
Gordon RY, Becker DJ. The role of red yeast rice for the physician. Curr Atheroscler Rep, 2011; 13:73–80.
Gouni-Berthold I, Berthold HK. Policosanol: clinical pharmacology and therapeutic
85
Greyling A, De Witt C, Oosthuizen W, Jerling JC. Effects of a policosanol supplement on
serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr, 2006; 95:968 –75.
Grooms KN, Ommerborn MJ, Pham do Q, Djoussé L, Clark CR. Dietary fiber intake and
cardiometabolic risks among US adults, NHANES 1999-2010. Am J Med, 2013; 126:1059-
1067.
Guardamagna O, Abello F, Baracco V, Stasiowska B, Martino F. The treatment of
hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. Nutr Metab Cardiovasc Dis, 2011; 21:424-429.
Gylling H, Plat J, Turley S, Ginsberg HN, Ellegård L, Jessup W, Jones PJ, Lütjohann D, Maerz W, Masana L, Silbernagel G, Staels B, Borén J, Catapano AL, De Backer G, Deanfield J, Descamps OS, Kovanen PT, Riccardi G, Tokgözoglu L, Chapman MJ; European Atherosclerosis Society Consensus Panel on Phytosterols. Plant sterols and plant stanols
in the management of dyslipidaemia and prevention of cardiovascular disease.
Atherosclerosis, 2014; 232:346-360.
Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Borén J, Bruckert E, Catapano AL, Descamps OS, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Stroes E, Taskinen MR, Tybjærg-Hansen A, Watts GF, Wiklund O. The polygenic nature of
hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet
Diabetes Endocrinol, 2014; 2:655–666.
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ. Forecasting the future of cardiovascular disease in the United
States: a policy statement from the American Heart Association. Circulation, 2011;
123:933–944.
Heinen MM, Verhage BA, Goldbohm RA, van den Brandt PA. Intake of vegetables, fruits,
carotenoids and vitamins C and E and pancreatic cancer risk in The Netherlands Cohort Study. Int J Cancer, 2012; 130: 147-158.
86
Holst B, Williamson G. A critical review of the bioavailability of glucosinolates and related
compounds. Nat Prod Rep, 2004; 21: 425-47.
Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis
vulgaris and its active constituent, berberina. Phytother Res, 2008; 22:999-1012.
Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, Kennedy BA, Hassell RG, Visser ME, Schwartz SM, Voight BF, Elosua R, Salomaa V, O'Donnell CJ, Dallinga-Thie GM, Anand SS, Yusuf S, Huff MW, Kathiresan S, Cao H, Hegele RA. An
increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arterioscler Thromb Vasc Biol, 2011;
31:1916–1926.
Jones MR, Nwose OM. Role of colesevelam in combination lipid-lowering therapy. Am J Cardiovasc Drugs, 2013; 13:315–323.
Jull AB, Ni Mhurchu C, Bennett DA, Dunshea-Mooij CA, Rodgers A. Chitosan for
overweight or obesity. Cochrane Database Syst Rev, 2008; 3:CD003892.
Kasper DL, Hauser SL, Fauci AS, Longo DL, Jameson JL, Loscalzo J. Harrison’s principles of
internal medicine. (2015).
Katsarou A, Tyrovolas S, Psaltopoulou T, Zeimbekis A, Tsakountakis N, Bountziouka V, Gotsis E, Metallinos G, Polychronopoulos E, Lionis C, Panagiotakos D. Socio-economic
status, place of residence and dietary habits among the elderly: the Mediterranean islands study. Public Health Nutr, 2010; 13:1614-1621.
Kay HY, Kim WD, Hwang SJ, Choi HS, et al. Nrf2 inhibits LXRalpha-dependent hepatic
lipogenesis by competing with FXR for acetylase binding. Antioxid. Redox Signal, 2011;
15, 2135–2146.
Ketomaki A, Gylling H, Miettinen TA. Effects of plant stanol and sterol esters on serum
phytosterols in a family with familial hypercholesterolemia including a homozygous subject. J Lab Clin Med, 2004; 143:255-262.
Kim JY, Park HJ, Um SH, Sohn EH, Kim BO, Moon EY, Rhee DK, Pyo S. Sulforaphane
87
vascular smooth muscle cells: involvement of the MAPK, NF-kappaB and AP-1 signaling pathways. Vasc Pharmacol, 2012; 56:131–41.
Kim SY, Yoon S, Kwon SM, Park KS, Lee-Kim, YC. Kale juice improves coronary artery
disease risk factors in hypercholesterolemic men. Biomed. Environ. Sci, 2008; 21, 91–97.
Kivela AM, Makinen PI, Jyrkkanen HK, Mella-Aho E, Xia Y, Kansanen E, Leinonen H, Verma IM, Yla-Herttuala S, Levonen AL. Sulforaphane inhibits endothelial lipase expression
through NFkappaB in endothelial cells. Atherosclerosis, 2010; 213:122–8.
Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD. Berberine is a novel cholesterol-lowering drug working
through a unique mechanism distinct from statins. Nat Med, 2004; 10:1344-1351.
Kong WJ, Wei J, Zuo ZY, Wang YM, Song DQ, You XF, Zhao LX, Pan HN, Jiang JD.
Combination of simvastatin with berberine improves the lipid-lowering efficacy.
Metabolism, 2008; 57:1029-1037.
Kwon JS, Joung H, Kim YS, Shim YS, Ahn Y, Jeong MH, Kee HJ. Sulforaphane inhibits
restenosis by suppressing inflammation and theproliferation of vascular smooth muscle cells. Atherosclerosis, 2012; 225:41–9.
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. Meta-analysis of the effect and safety
of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
J Ethnopharmacol, 2015; 161:69-81.
Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J. Effects of extended-release niacin with laropiprant in high-
risk patients. N Engl J Med, 2014; 371:203–212.
Lee S, Lim HJ, Park JH, Lee KS, Jang Y, Park HY. Berberine induced LDLR upregulation
involves JNK pathway. Biochem Biophys Res Commun, 2007; 362:853–857.
Li Y, Jiang L, Jia Z, Xin W, Yang S, Yang Q, Wang L. A meta-analysis of red yeast rice: an
effective and relatively safe alternative approach for dyslipidemia. PLoS One, 2014;
9:e98611.
Lichtenstein AH, Deckelbaum RJ. AHA Science Advisory. Stanol/sterol ester-containing
88
Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation, 2001; 103:1177-1179.
Lin Y, Rudrum M, van der Wielen RP, et al. Wheat germ policosanol failed to lower
plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations.
Metabolism, 2004; 53:1309 –14.
Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V. Chinese red yeast rice (Monascus
purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.
Chin Med, 2006; 1:4.
Liu K, Daviglus ML, Loria CM, Colangelo LA, Spring B, Moller AC, Lloyd-Jones DM. Healthy
lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study. Circulation, 2012; 125:996–1004.
Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, Morgan JM, Capuzzi DM; Chinese Coronary Secondary Prevention Study Group, Li S. Effect of Xuezhikang, an extract from red yeast